blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1177439

EP1177439 - SCREENING FOR IMMUNOSTIMULATORY DNA FUNCTIONAL MODIFIERS [Right-click to bookmark this link]
Former [2002/06]SCREENING FOR IMMUNOSTIMULATORY DNA FUNCTIONAL MODIFYERS
[2004/35]
StatusNo opposition filed within time limit
Status updated on  15.07.2005
Database last updated on 11.09.2024
Most recent event   Tooltip14.12.2007Lapse of the patent in a contracting state
New state(s): PT		published on 16.01.2008  [2008/03]
Applicant(s)For all designated states
Coley Pharmaceutical GmbH
Elisabeth-Selbert-Strasse 9
40764 Langenfeld / DE
For all designated states
UNIVERSITY OF IOWA RESEARCH FOUNDATION
214 Technology Innovation Center, Oakdale Research Campus
Iowa City, IA 52242 / US
[N/P]
Former [2002/06]For all designated states
Coley Pharmaceutical GmbH
Elisabeth-Selbert-Strasse 9
40764 Langenfeld / DE
For all designated states
UNIVERSITY OF IOWA RESEARCH FOUNDATION
214 Technology Innovation Center, Oakdale Research Campus
Iowa City, IA 52242 / US
Inventor(s)01 / NOLL, Berhard, O.
Birkenstrasse 70
D-40233 Duesseldorf / DE
02 / SCHETTER, Christian
Oerkhaushof 35
D-40723 Hilden / DE
03 / KRIEG, Arthur, M.
890 Park Place
Iowa City, IA 52246 / US
 [2002/06]
Representative(s)Jump, Timothy John Simon, et al
Venner Shipley LLP
200 Aldersgate
London EC1A 4HD / GB
[N/P]
Former [2002/06]Jump, Timothy John Simon, et al
Venner Shipley & Co. 20 Little Britain
London EC1A 7DH / GB
Application number, filing date00931983.128.04.2000
[2002/06]
WO2000US11697
Priority number, dateUS19990131830P29.04.1999         Original published format: US 131830 P
US20000186845P03.03.2000         Original published format: US 186845 P
[2002/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0067023
Date:09.11.2000
Language:EN
[2000/45]
Type: A1 Application with search report 
No.:EP1177439
Date:06.02.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 09.11.2000 takes the place of the publication of the European patent application.
[2002/06]
Type: B1 Patent specification 
No.:EP1177439
Date:08.09.2004
Language:EN
[2004/37]
Search report(s)International search report - published on:EP09.11.2000
ClassificationIPC:G01N33/50, G01N33/68, C12Q1/68, C07K14/47
[2002/06]
CPC:
G01N33/502 (EP); C07K14/4705 (EP); G01N33/5008 (EP);
G01N33/5047 (EP); G01N2333/47 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2004/37]
Former [2002/06]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:SCREENING NACH MODULATOREN DER FUNKTION VON IMMUNSTIMULATORISCHER DNA[2002/06]
English:SCREENING FOR IMMUNOSTIMULATORY DNA FUNCTIONAL MODIFIERS[2004/35]
French:CRIBLAGE DE MODIFICATEURS FONCTIONNELS DE L'ADN IMMUNOSTIMULANT[2002/06]
Former [2002/06]SCREENING FOR IMMUNOSTIMULATORY DNA FUNCTIONAL MODIFYERS
Entry into regional phase28.11.2001National basic fee paid 
28.11.2001Designation fee(s) paid 
28.11.2001Examination fee paid 
Examination procedure15.11.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
28.11.2001Examination requested  [2002/06]
28.01.2002Amendment by applicant (claims and/or description)
11.04.2003Despatch of a communication from the examining division (Time limit: M04)
22.08.2003Reply to a communication from the examining division
21.11.2003Communication of intention to grant the patent
01.04.2004Fee for grant paid
01.04.2004Fee for publishing/printing paid
Opposition(s)09.06.2005No opposition filed within time limit [2005/35]
Request for further processing for:22.08.2003Request for further processing filed
22.08.2003Full payment received (date of receipt of payment)
Request granted
11.09.2003Decision despatched
Fees paidRenewal fee
25.03.2002Renewal fee patent year 03
22.04.2003Renewal fee patent year 04
26.04.2004Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
FR08.09.2004
IT08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
PT08.02.2005
CY28.04.2005
GB28.04.2005
IE28.04.2005
LU28.04.2005
MC30.04.2005
[2008/03]
Former [2007/35]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
FR08.09.2004
IT08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
CY28.04.2005
GB28.04.2005
IE28.04.2005
LU28.04.2005
MC30.04.2005
Former [2007/27]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
FR08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
CY28.04.2005
GB28.04.2005
IE28.04.2005
LU28.04.2005
MC30.04.2005
Former [2007/26]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
FR08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
CY28.04.2005
GB28.04.2005
IE28.04.2005
LU28.04.2005
Former [2007/20]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
FR08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
CY28.04.2005
GB28.04.2005
IE28.04.2005
LU30.04.2005
Former [2007/08]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
FR08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
GB28.04.2005
IE28.04.2005
LU30.04.2005
Former [2006/32]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
FR08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
GB28.04.2005
IE28.04.2005
Former [2006/25]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
GB28.04.2005
IE28.04.2005
Former [2006/14]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
GB28.04.2005
Former [2006/13]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
NL08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
GB28.04.2005
Former [2005/46]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
Former [2005/28]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
Former [2005/27]AT08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
GR08.12.2004
SE08.12.2004
ES19.12.2004
Former [2005/21]AT08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
GR08.12.2004
SE08.12.2004
Former [2005/18]AT08.09.2004
FI08.09.2004
GR08.12.2004
SE08.12.2004
Former [2005/13]AT08.09.2004
FI08.09.2004
SE08.12.2004
Former [2005/11]FI08.09.2004
SE08.12.2004
Former [2005/10]SE08.12.2004
Cited inInternational search[A]WO9602555  (UNIV IOWA RES FOUND [US]) [A] 1-104 * the whole document *;
 [A]WO9840100  (OTTAWA CIVIC LOEB RES INST [CA], et al) [A] 1-104 * page 12 *;
 [DA]  - KRIEG, A.M., "The CpG Motif: Implications for Clinical Immunology", BIODRUGS, (199811), vol. 10, no. 5, pages 341 - 346, XP000949909 [DA] 1-104 * the whole document *

DOI:   http://dx.doi.org/10.2165/00063030-199810050-00001
 [A]  - HÄCKER, H. ET AL., "CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation", THE EMBO JOURNAL, (19981102), vol. 17, no. 21, pages 6230 - 6240, XP000946495 [A] 1-104 * the whole document *

DOI:   http://dx.doi.org/10.1093/emboj/17.21.6230
 [DA]  - KRIEG A M ET AL, "CPG MOTIFS IN BACTERIAL DNA TRIGGER DIRECT B-CELL ACTIVATION", NATURE,GB,MACMILLAN JOURNALS LTD. LONDON, (19950406), vol. 374, ISSN 0028-0836, pages 546 - 549, XP000197060 [DA] 1-104 * the whole document *

DOI:   http://dx.doi.org/10.1038/374546a0
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.